Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Mi | Akobo Minerals AB (publ): Akobo Minerals Closes NOK 11 Million Convertible Loan | ||
Mi | Oncoinvent ASA: Minutes from the annual general meeting 2025 | ||
Mi | SpareBank 1 SMN: Successful issuance of Additional Tier 1 bond | ||
Mi | Wallenius Wilhelmsen ASA: Wallenius Wilhelmsen: Allocation of shares under the long-term incentive program | ||
Mi | Norwegian Air Shuttle ASA - Minutes from the Annual General Meeting 2025 | ||
Mi | Salmon Evolution ASA: Notice of annual general meeting 2025 | ||
Mi | Pexip Holding ASA: Mandatory notification of trade by Primary Insiders | ||
Mi | Resolution for transfer of 3T Global Bidco Plc bonds from Euronext ABM to Euronext Oslo Børs | ||
Mi | Golden Ocean Group Limited: Shareholder Disclosure Notification | ||
Mi | Gentoo Media Inc.: Gentoo Media - Mandatory notification of trade | ||
Mi | Endúr ASA: Endúr ASA - New share capital registered | ||
Mi | Olav Thon Eiendomsselskap ASA: REPORT FOR Q1-2025 | ||
Mi | Elmera Group ASA: Mandatory notification of trade | ||
Mi | CodeLab Capital AS: Financial calendar | ||
Mi | Spotlio AS: Received application for delisting | ||
Mi | KINGDOM OF NORWAY: Result of issuing auction NGB 09/2029 and NGB 10/2042 | ||
Mi | Grieg Seafood ASA: Notice of the Annual General Meeting 2025 | ||
Mi | 3T Global Bidco Plc: Received application for deregistration and migration to Euronext Oslo Børs | ||
Mi | Nordea Bank Abp: Composition of Nordea's Shareholders' Nomination Board | ||
Mi | Selvaag Bolig ASA: Invitation to presentation of first quarter 2025 results | ||
Mi | XXL ASA - Notice of Annual General Meeting 2025 | ||
Mi | SWEDBANK AB: Comment to the SFSA decision on an administrative fine | ||
Mi | SpareBank 1 Østlandet: Buy-back of Additional Tier 1: SPOL61 PRO | ||
Mi | Saga Pure ASA - Final results of the mandatory offer by Tycoon Industrier AS to acquire all shares in Saga Pure ASA - Disclosure of large shareholding | ||
Mi | EXACT Therapeutics AS: EXACT Therapeutics announces grant of key patent covering non-invasive delivery of pharmaceuticals to the brain |